Global Clinical Trials Software Market

Report ID : 1195 | Published : 2022-03-18 | Pages: | Format:

The global Clinical Trials Software market size was accounted at USD 4.13 Bn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 37% from 2022 to 2030. Recently pharmaceutical companies started using clinical trial management services to improve the accuracy and efficiency of clinical trials. A clinical trial is a procedure that studies new treatments and drugs to check their effects on human health.

The rising use of clinical trial management services, fast adoption of cloud-based solutions, increased healthcare expenditure, high prevalence of chronic & infectious diseases, growing government investments for clinical trial services and research are projected to augument the market growth over the forecast period. Furthermore, rising innovations of clinical trials software drive the market growth. For instance, in April 2021, Bioclinica (US) introduced the new source document management solution that combines advanced software with redaction and translation services to offer support to global research sites and trial management teams.

However, the expensive clinical trials software and limited knowledge on advanced technologies among healthcare professionals may restrict the market growth during the estimated timeframe.

The clinical trials software market is segmented into the type of deployment, type of delivery, features of software, end-users, and region. The type of deployment segment comprises on-cloud and on-premises. The on-cloud segment is projected to dominate the market during the forecast period due to the surging use of cloud-based software for clinical trials. The market is classified into web-based and remote monitoring based on the type of delivery. The web-based delivery type is expected to be the fastest-growing segment of this market. It reduces R&D costs and offers cost-effective, easy accessibility to web-based clinical trial solutions. The market is grouped into EDC, eCOA/ePRO, and eConsent by features of software. The market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), medical device manufacturers, and others by end-users. The pharmaceutical & biotechnology companies will lead this market in the coming years due to the high demand for automated clinical trial management services. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

North America has dominated the clinical trials software market in 2020 and will continue its trend over the forecast period. Additionally, the Asia-Pacific market is likely to witness rapid growth in the next few years due to the growing pharmaceutical companies, increasing clinical trial studies, and high demand for web-based and cloud-based solutions for clinical trial processes.

Some of the key players operating in the clinical trials software market are Advarra, Antidote Technologies, Inc., ArisGlobal , AssistRx, athenahealth, Inc., Axiom Real-Time Metrics, BioClinica Inc. , BSI Business Systems Integration AG, Calyx , Castor EDC, Chronicles, Clario, Clarivate, ClinCapture, Clincase, Clinical Research, CLIRINX, Cloudbyz, Dacima Software Inc., Datatrak Int. , Florence HC , IBM , Instem , IQVIA , MasterControl Inc., Medidata Solutions Inc, MedNet Solutions Inc., Novatek International, Octalsoft , Openclinica, Oracle Corporation, Parexel International Corp., RealTime Software Solutions LLC, Reify Health, Inc., Signant Health, Statsols, TrialKit , Veeva Systems Inc., WIRB-Copernicus Group, and Other prominent players.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Clinical Trials Software Market Snapshot

Chapter 4. Global Clinical Trials Software Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 2: By Type of Deployment Estimates & Trend Analysis

5.1. By Type of Deployment & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Type of Deployment:

5.2.1. On-cloud

5.2.2. On-premises

Chapter 6. Market Segmentation 3: By Features of software Estimates & Trend Analysis

6.1. By Features of software & Market Share, 2020& 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Features of software:

6.2.1. EDC

6.2.2. eCOA/ePRO

6.2.3. eConsent

Chapter 7. Market Segmentation 4: By Type of Delivery Estimates & Trend Analysis

7.1. By Type of Delivery & Market Share, 2020& 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Type of Delivery:

7.2.1. Web-based

7.2.2. Remote Monitoring

Chapter 8. Market Segmentation 4: By End-user Estimates & Trend Analysis

8.1. By End-user & Market Share, 2020& 2030

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-user:

8.2.1. Pharmaceutical & Biotechnology Companies

8.2.2. Contract Research Organizations (CROs)

8.2.3. Medical Device Manufacturers

8.2.4. Others

Chapter 9. Clinical Trials Software Market Segmentation 6: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Clinical Trials Software Market revenue (US$ Million) estimates and forecasts By Type of Deployment, 2020-2030

9.1.2. North America Clinical Trials Software Market revenue (US$ Million) estimates and forecasts By Features of software, 2020-2030

9.1.3. North America Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by Type of Delivery, 2020-2030

9.1.4. North America Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

9.1.5. North America Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by end-user, 2020-2030

9.2. Europe

9.2.1. Europe Clinical Trials Software Market revenue (US$ Million) By Type of Deployment, 2020-2030

9.2.2. Europe Clinical Trials Software Market revenue (US$ Million) By Features of software , 2020-2030

9.2.3. Europe Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by Type of Delivery, 2020-2030

9.2.4. Europe Clinical Trials Software Market revenue (US$ Million) by country, 2020-2030

9.2.5. Europe Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by end-user, 2020-2030

9.3. Asia Pacific

9.3.1. Asia Pacific Clinical Trials Software Market revenue (US$ Million) By Type of Deployment, 2020-2030

9.3.2. Asia Pacific Clinical Trials Software Market revenue (US$ Million) By Features of software , 2020-2030

9.3.3. Asia Pacific Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by Type of Delivery, 2020-2030

9.3.4. Asia Pacific Clinical Trials Software Market revenue (US$ Million) by country, 2020-2030

9.3.5. Asia Pacific Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by end-user, 2020-2030

9.4. Latin America

9.4.1. Latin America Clinical Trials Software Market revenue (US$ Million) By Type of Deployment, 2020-2030

9.4.2. Latin America Clinical Trials Software Market revenue (US$ Million) By Features of software , 2020-2030

9.4.3. Latin America Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by Type of Delivery, 2020-2030

9.4.4. Latin America Clinical Trials Software Market revenue (US$ Million) by country, 2020-2030

9.4.5. Latin America Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by end-user, 2020-2030

9.5. Middle East & Africa

9.5.1. Middle East & Africa Clinical Trials Software Market revenue (US$ Million) By Type of Deployment, 2020-2030

9.5.2. Middle East & Africa Clinical Trials Software Market revenue (US$ Million) By Features of software , 2020-2030

9.5.3. Middle East & Africa Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by Type of Delivery, 2020-2030

9.5.4. Middle East & Africa Clinical Trials Software Market revenue (US$ Million) by country, (US$ Million) 2020-2030

9.5.5. Middle East & Africa Clinical Trials Software Market revenue (US$ Million) estimates and forecasts by end-user, 2020-2030

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Advarra

10.2.2. Antidote Technologies, Inc.

10.2.3. ArisGlobal

10.2.4. AssistRx

10.2.5. athenahealth, Inc.

10.2.6. Axiom Real-Time Metrics

10.2.7. BioClinica Inc.

10.2.8. BSI Business Systems Integration AG

10.2.9. Calyx

10.2.10. Castor EDC

10.2.11. Chronicles

10.2.12. Clario

10.2.13. Clarivate

10.2.14. ClinCapture

10.2.15. Clincase

10.2.16. Clinical Research

10.2.17. CLIRINX

10.2.18. Cloudbyz

10.2.19. Dacima Software Inc.

10.2.20. Datatrak Int.

10.2.21. Florence HC

10.2.22. IBM

10.2.23. Instem

10.2.24. IQVIA

10.2.25. MasterControl Inc.

10.2.26. Medidata Solutions Inc

10.2.27. MedNet Solutions Inc.

10.2.28. Novatek International

10.2.29. Octalsoft

10.2.30. Openclinica

10.2.31. Oracle Corporation

10.2.32. Parexel International Corp.

10.2.33. RealTime Software Solutions LLC

10.2.34. Reify Health, Inc.

10.2.35. Signant Health

10.2.36. Statsols

10.2.37. TrialKit

10.2.38. Veeva Systems Inc.

10.2.39. WIRB-Copernicus Group

10.2.40. Other prominent players

Global Clinical Trials Software Market, by Type of Deployment, 2019-2030 (Value US$ Mn)

  • On-cloud
  • On-premises

Global Clinical Trials Software Market, by Type of Delivery, 2019-2030 (Value US$ Mn)

  • Web-based
  • Remote Monitoring

Global Clinical Trials Software Market, by Features of software, 2019-2030 (Value US$ Mn)

  • EDC
  • eCOA/ePRO
  • eConsent

Global Clinical Trials Software Market, by End-Users, 2019-2030 (Value US$ Mn)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Medical Device Manufacturers
  • Others

Global Clinical Trials Software Market, by Region, 2019-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Clinical Trials Software Market, by Country, 2019-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe Clinical Trials Software Market, by Country, 2019-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Clinical Trials Software Market, by Country, 2019-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Clinical Trials Software Market, by Country, 2019-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Clinical Trials Software Market, by Country, 2019-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development

Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients